Newspaper logo  
 
 
Local News & Opinion

Ref. : Civic Events

Ref. : Arts & Education Events

Ref. : Public Service Notices

Travel
Books, Films, Arts & Education

09.22 For-Profit Colleges as Factories of Debt

09.21 ‘Poor people don’t plan long-term. We’ll just get our hearts broken’

09.19 Texas proposes rewriting school text books to deny manmade climate change

Letters
Open Letters:

Ref. : Letters to the editor

Health Care & Environment

09.22 Bottom-Up Climate Fix

09.22 Rockefellers, Heirs to an Oil Fortune, Will Divest Charity From Fossil Fuels

09.22 Climate change marches: Kerry cites fight against Ebola and Isis as thousands join protests

09.22 De Blasio Orders a Greener City, Setting Goals for Energy Efficiency of Buildings

09.21 After Surgery, Surprise $117,000 Medical Bill From Doctor He Didn’t Know

09.21 Climate warning to world leaders: stick to 2C limit or face 'mayhem'

09.21 Desmond Tutu: We fought apartheid. Now climate change is our global enemy

09.21 Thousands join People's Climate March around the world – live

09.21 Climate change is a global emergency. Stop waiting for politicians to sound the alarm

09.21 US will not commit to climate change aid for poor nations at UN summit

09.20 Climate Change: The Next Generation [25:26 video]

09.20 These Stunning Photos of Greenland's "Dark Snow" Should Worry You

09.20 Artificial Sweeteners May Disrupt Body’s Blood Sugar Controls

09.19 Texas proposes rewriting school text books to deny manmade climate change

09.19 Jarvis Cocker: Do I Really Have to March?

News Media

09.19 How the Media Gets It Wrong

09.18 At Elite Media, ‘Scientific’ Racists Fit in Fine

Daily FAIR Blog
The Daily Howler

Justice Matters

09.20 Financial Criminals Have Been Fined Billions, but They Rarely Pay

09.20 Science’s Sexual Assault Problem

US Politics, Policy & Culture

09.22 How the GOP stopped caring about you

09.21 Spatial Justice: Rasquachification, Race and the City

09.20 "Washington Is a Cesspool of Faux-Experts Who Do Bad Research"

09.20 Does Hillary Clinton Have Anything to Say?

09.19 Police Have a Much Bigger Domestic Abuse Problem Than the NFL

09.19 Chris Christie lies yet again. Tells press conference that Sirota was fired by Pando over inaccuracies

High Crimes?
Economics, Crony Capitalism

09.20 5 Signs the Dark-Money Apocalypse Is Upon Us

09.20 Climate Change Is an Opportunity to Dramatically Reinvent the Economy

09.18 Bill Black: The New York Times’ Coverage of EU Austerity Remains Pathetic

09.18 The Deficit Disaster That Never Was [charts]

09.18 Hey, FCC: do your job and stand up for net neutrality, not Big Cable schemes

International

09.22 Fleeing ISIS, 130,000 Syrians Have Entered Turkey in Just Four Days

09.22 How Sugar Daddies Are Financing College Education

09.22 What Happens When We All Live to 100?

09.22 Why I Hope to Die at 75

09.22 In a Mattress, a Fulcrum of Art and Political Protest

09.22 Syrian Kurdish fighters halt Islamic State advance near Kobani

09.21 Germany's Ailing Infrastructure: A Nation Slowly Crumbles

09.21 Mikhail Khodorkovsky breaks political silence, saying he would lead Russia

09.21 Kurds call on 'all Middle East' to help defend stronghold from Isis

09.19 How Malawi Women Are Turning Waste Into Wealth

09.19 5 Key Themes Emerging From the 'New Science of Cities'

09.19 The rapid pace of technology is hollowing out the middle class

09.19 Scotland votes no: the union has survived, but the questions for the left are profound

We are a non-profit Internet-only newspaper publication founded in 1973. Your donation is essential to our survival.

You can also mail a check to:
Baltimore News Network, Inc.
P.O. Box 42581
Baltimore, MD 21284-2581
Google
This site Web
  Big Pharma Wins Big in Health Care Reform

COMMENTARY:

Big Pharma Wins Big in Health Care Reform

by James Ridgeway
First published in his blog Unsilent Generation yesterday, 22 March 2010
To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Members of Congress in both parties generally have lined up behind the insurance and pharmaceutical industries from the get go. So it should come as no surprise that the Democrats, who long ago gave up any pretence of opposing corporate power, found a way to accomodate the pharmaceutical companies on the way to its tepid reform. To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

In fact, the Dems actually made the drugsters look good, celebrating the industry’s generous “concessions” and “discounts” while ensuring that no real threat to Big Pharma’s profits would make their way into the final bill.

The industry’s main goal from the very beginning has been to fend off any government power to negotiate or seriously regulate drug prices–and this they did.

Big Pharma’s second big win was to prevent any measure that would have opened the way for American consumers to buy less expensive drugs abroad, especially from Canada.

At the same time, the supposed give-backs by the drug industry are projected to more than pay for themselves. The much-lauded discounts on brand name drugs for seniors in the Medicare prescription drug program, for example, are good for Big Pharma because they discourage oldsters from switching to generics.

And more insured people simply mean more money coming into the coffers, for Big Pharma as well as for the insurance industry.

Confirmation of the industry analysis came early in the day from the stock market, where drug stocks initially remained level; there certainly was no rush to dump shares, which is what would be expected if the bill actually represented any threat to profits. And by 1 p, EST, CNN Money was reporting a rally in health care stocks.

“I was unable to find anything in there that would cause me to have anxiety if I were a shareholder in a pharmaceutical company,” Ira Loss, a senior health-care analyst at the research firm Washington Analysis, told Dow Jones. According to the ticker story:

Billy Tauzin, who led the industry’s negotiations on health care with lawmakers, said overall drug makers fare well. “While we’re not totally happy,” Tauzin began, “we generally feel like it tracks with our principles.”

Sanofi-Aventis SA (SNY) Chief Executive Christopher Viehbacher said in an interview that the impact of the legislation will be neutral to slightly negative “but better for the industry than if healthcare reform didn’t pass.”

Tauzin, head of the Pharmaceutical Research and Manufacturers of America or PhRMA, and Viehbacher said getting protection for brand-name biologics is among the important provisions for the industry. Drug makers pushed hard to get 12 years of exclusive market protection while the White House and some lawmakers wanted to lower the protection to seven years.

Despite fees and rebates imposed by the legislation, “analysts say drug makers will end up recouping those costs through new customers: The bill would provide insurance coverage to an additional 32 million Americans.” The Dow Jones story continues:

Chalk up another good round for Pharma and Biotech in health care reform,” began a note to clients Friday from Concept Capital, a research firm.Ken Tsuboi, co-manager of the Allianz RCM Wellness Fund, sees the impact of bill, and its $90 billion in concessions over 10 years, as relatively minor in an industry that has annual global sales of about $750 billion, with about $300 billion in the U.S., and margins close to 30%.”I think that it is actually a pretty good deal for Pharma,” Tsuboi said.

The GOP, which purports to be the party of big business, ought to be applauding at least these portions of the health care reform—and perhaps when the cameras go away, some of them will quit bitching and count their blessings. As for the obnoxious Tea Party gang, if they start threatening the real power in this country, which is vested in corporations, they may well find themselves whipped and isolated.


Born in 1936, James Ridgeway has been reporting on politics for more than 45 years. He is currently Senior Washington Correspondent for Mother Jones, and recently wrote a blog on the 2008 presidential election for the Guardian online. He previously served as Washington Correspondent for the Village Voice; wrote for Ramparts and The New Republic; and founded and edited two independent newsletters, Hard Times and The Elements.

Ridgeway is the author of 16 books, including The Five Unanswered Questions About 9/11, It’s All for Sale: The Control of Global Resources, and Blood in the Face: The Ku Klux Klan, Aryan Nations, Nazi Skinheads, and the Rise of a New White Culture. He co-directed a companion film to Blood in the Face and a second documentary film, Feed, and has co-produced web videos for GuardianFilms.

Additional information and samples of James Ridgeway’s work can be found at JamesRidgeway.net and at his newest web site, Solitary Watch.

This article is republished in the Baltimore Chronicle with permission of the author.



Copyright © 2010 The Baltimore News Network. All rights reserved.

Republication or redistribution of Baltimore Chronicle content is expressly prohibited without their prior written consent.

Baltimore News Network, Inc., sponsor of this web site, is a nonprofit organization and does not make political endorsements. The opinions expressed in stories posted on this web site are the authors' own.

This story was published on March 23, 2010.
 



Public Service Ads:
Verifiable Voting in Maryland